Natural Killer cells treated with a combination of IL-2 and IL-12 exhibit enhanced in vitro cytolytic activity and lyse neuroblastoma cells (Rossi et al, 1994) and human osteosarcoma cells more efficiently (Mariani et al, 2000). The gene discussed is IL2; the disease is neuroblastoma.